$ACER Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in Acer Therapeutics Inc..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of all insider trading transactions in Acer Therapeutics Inc.. Get notifications about new insider transactions in Acer Therapeutics Inc. for free.
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Mar 04 2014 | OPXA | Opexa Therapeutics ... | Richman Michael | Director | Grant | A | 0.00 | 8,242 | 0 | 8,242 | 0 to 8.2 K |
Mar 04 2014 | OPXA | Opexa Therapeutics ... | Radhakrishnan Karthik | Chief Financial Off ... | Option Exercise | A | 1.82 | 64,625 | 117,618 | 64,625 | |
Mar 04 2014 | OPXA | Opexa Therapeutics ... | Radhakrishnan Karthik | Chief Financial Off ... | Grant | A | 0.00 | 16,659 | 0 | 74,659 | 58 K to 74.7 K (+28.72 %) |
Dec 18 2013 | OPXA | Opexa Therapeutics ... | Seaman Scott B | Director | Buy | P | 1.70 | 30,000 | 51,000 | 40,913 | 10.9 K to 40.9 K (+274.90 %) |
Dec 18 2013 | OPXA | Opexa Therapeutics ... | Radhakrishnan Karthik | Chief Financial Off ... | Buy | P | 1.70 | 8,000 | 13,600 | 58,000 | 50 K to 58 K (+16.00 %) |
Nov 12 2013 | OPXA | Opexa Therapeutics ... | Warma Neil K | President & CEO | Option Exercise | A | 1.88 | 50,000 | 94,000 | 50,000 | |
Nov 12 2013 | OPXA | Opexa Therapeutics ... | Warma Neil K | President & CEO | Grant | A | 0.00 | 28,571 | 0 | 45,886 | 17.3 K to 45.9 K (+165.01 %) |
Nov 12 2013 | OPXA | Opexa Therapeutics ... | Rill Donna R | Chief Development O ... | Grant | A | 0.00 | 20,000 | 0 | 20,402 | 402 to 20.4 K (+4,975.12 %) |
Sep 26 2013 | OPXA | Opexa Therapeutics ... | Warma Neil K | President & CEO | Buy | C | 1.91 | 8,076 | 15,425 | 17,315 | 9.2 K to 17.3 K (+87.41 %) |
Sep 26 2013 | OPXA | Opexa Therapeutics ... | JORDEN DAVID EMERSON | Director | Buy | C | 1.91 | 61,912 | 118,252 | 293,456 | 231.5 K to 293.5 K (+26.74 %) |
Sep 26 2013 | OPXA | Opexa Therapeutics ... | Seaman Scott B | Director | Buy | C | 1.91 | 269,182 | 514,138 | 518,708 | 249.5 K to 518.7 K (+107.88 %) |
Jul 02 2013 | OPXA | Opexa Therapeutics ... | JORDEN DAVID EMERSON | Director | Grant | A | 1.54 | 4,450 | 6,853 | 231,544 | 227.1 K to 231.5 K (+1.96 %) |
Aug 09 2013 | OPXA | Opexa Therapeutics ... | Radhakrishnan Karthik | Chief Financial Off ... | Buy | P | 1.50 | 50,000 | 75,000 | 50,000 | 0 to 50 K |
Jul 02 2013 | OPXA | Opexa Therapeutics ... | Warma Neil K | President & CEO | Grant | A | 1.54 | 581 | 895 | 9,239 | 8.7 K to 9.2 K (+6.71 %) |
Jul 02 2013 | OPXA | Opexa Therapeutics ... | Seaman Scott B | Director | Grant | A | 1.54 | 19,345 | 29,791 | 249,526 | 230.2 K to 249.5 K (+8.40 %) |
May 01 2013 | OPXA | Opexa Therapeutics ... | Rill Donna R | Chief Development O ... | Option Exercise | A | 1.75 | 20,000 | 35,000 | 20,000 | |
May 01 2013 | OPXA | Opexa Therapeutics ... | Rill Donna R | Chief Development O ... | Option Exercise | A | 3.80 | 20,939 | 79,568 | 20,939 | |
May 01 2013 | OPXA | Opexa Therapeutics ... | Rill Donna R | Chief Development O ... | Grant | A | 0.00 | 20,000 | 0 | 20,402 | 402 to 20.4 K (+4,975.12 %) |
May 01 2013 | OPXA | Opexa Therapeutics ... | Richman Michael | Director | Option Exercise | A | 1.75 | 17,143 | 30,000 | 17,143 | |
May 01 2013 | OPXA | Opexa Therapeutics ... | Richman Michael | Director | Option Exercise | A | 1.75 | 5,000 | 8,750 | 5,000 | |
May 01 2013 | OPXA | Opexa Therapeutics ... | Warma Neil K | President & CEO | Option Exercise | A | 1.75 | 50,000 | 87,500 | 50,000 | |
May 01 2013 | OPXA | Opexa Therapeutics ... | Warma Neil K | President & CEO | Option Exercise | A | 3.80 | 95,970 | 364,686 | 95,970 | |
May 01 2013 | OPXA | Opexa Therapeutics ... | Warma Neil K | President & CEO | Grant | A | 0.00 | 28,571 | 0 | 37,229 | 8.7 K to 37.2 K (+330.00 %) |
May 01 2013 | OPXA | Opexa Therapeutics ... | Maderis Gail J | Director | Option Exercise | A | 1.75 | 17,143 | 30,000 | 17,143 | |
May 01 2013 | OPXA | Opexa Therapeutics ... | Maderis Gail J | Director | Option Exercise | A | 1.75 | 5,000 | 8,750 | 5,000 | |
May 01 2013 | OPXA | Opexa Therapeutics ... | JORDEN DAVID EMERSON | Director | Option Exercise | A | 1.75 | 17,143 | 30,000 | 17,143 | |
May 01 2013 | OPXA | Opexa Therapeutics ... | JORDEN DAVID EMERSON | Director | Option Exercise | A | 1.75 | 5,000 | 8,750 | 5,000 | |
May 01 2013 | OPXA | Opexa Therapeutics ... | Seaman Scott B | Director | Option Exercise | A | 1.75 | 17,143 | 30,000 | 17,143 | |
May 01 2013 | OPXA | Opexa Therapeutics ... | Seaman Scott B | Director | Option Exercise | A | 1.75 | 5,000 | 8,750 | 5,000 | |
Apr 01 2013 | OPXA | Opexa Therapeutics ... | Radhakrishnan Karthik | Chief Financial Off ... | Option Exercise | A | 2.34 | 125,000 | 292,500 | 125,000 | |
Feb 19 2013 | OPXA | Opexa Therapeutics ... | Seaman Scott B | Director | Option Exercise | S | 8.00 | 1,318 | 10,544 | 0 | |
Feb 19 2013 | OPXA | Opexa Therapeutics ... | Seaman Scott B | Director | Option Exercise | S | 8.00 | 11,966 | 95,728 | 1,318 | |
Feb 19 2013 | OPXA | Opexa Therapeutics ... | Seaman Scott B | Director | Option Exercise | S | 8.00 | 36,691 | 293,528 | 13,284 | |
Feb 19 2013 | OPXA | Opexa Therapeutics ... | Seaman Scott B | Director | Option Exercise | S | 8.00 | 25 | 200 | 49,975 | |
Jan 31 2013 | OPXA | Opexa Therapeutics ... | JORDEN DAVID EMERSON | Acting Chief Financ ... | Option Exercise | A | 1.21 | 5,278 | 6,386 | 5,278 | |
Jan 31 2013 | OPXA | Opexa Therapeutics ... | Seaman Scott B | Director | Option Exercise | A | 1.21 | 22,950 | 27,770 | 22,950 | |
Jan 31 2013 | OPXA | Opexa Therapeutics ... | Warma Neil K | President & CEO | Option Exercise | A | 1.21 | 688 | 832 | 688 | |
Jan 28 2013 | OPXA | Opexa Therapeutics ... | Warma Neil K | President & CEO | Option Exercise | A | 3.80 | 43,623 | 165,767 | 43,623 | |
Jan 28 2013 | OPXA | Opexa Therapeutics ... | Warma Neil K | President & CEO | Grant | A | 1.33 | 600 | 798 | 8,658 | 8.1 K to 8.7 K (+7.45 %) |
Jan 25 2013 | OPXA | Opexa Therapeutics ... | Thompson Jaye | SVP Clinical Dev & ... | Option Exercise | A | 3.80 | 10,469 | 39,782 | 10,469 | |
Jan 25 2013 | OPXA | Opexa Therapeutics ... | Rill Donna R | SVP Operations & Qu ... | Option Exercise | A | 3.80 | 10,469 | 39,782 | 10,469 | |
Jan 24 2013 | OPXA | Opexa Therapeutics ... | Seaman Scott B | Director | Grant | A | 1.33 | 19,978 | 26,571 | 230,181 | 210.2 K to 230.2 K (+9.50 %) |
Jan 24 2013 | OPXA | Opexa Therapeutics ... | JORDEN DAVID EMERSON | Acting Chief Financ ... | Option Exercise | A | 1.24 | 37,500 | 46,500 | 37,500 | |
Jan 24 2013 | OPXA | Opexa Therapeutics ... | JORDEN DAVID EMERSON | Acting Chief Financ ... | Grant | A | 1.33 | 4,595 | 6,111 | 227,094 | 222.5 K to 227.1 K (+2.07 %) |
Aug 16 2012 | OPXA | Opexa Therapeutics ... | JORDEN DAVID EMERSON | Acting Chief Financ ... | Option Exercise | A | 0.51 | 75,000 | 38,250 | 75,000 | |
Jul 27 2012 | OPXA | Opexa Therapeutics ... | Seaman Scott B | Director | Option Exercise | A | 1.25 | 468,750 | 585,938 | 468,750 | |
Jul 27 2012 | OPXA | Opexa Therapeutics ... | JORDEN DAVID EMERSON | Director | Option Exercise | A | 1.25 | 107,813 | 134,766 | 107,813 | |
Jul 27 2012 | OPXA | Opexa Therapeutics ... | Warma Neil K | President & CEO | Option Exercise | A | 1.25 | 14,063 | 17,579 | 14,063 | |
Mar 05 2012 | OPXA | Opexa Therapeutics ... | JORDEN DAVID EMERSON | Director | Option Exercise | A | 0.94 | 20,600 | 19,364 | 20,600 | |
Mar 05 2012 | OPXA | Opexa Therapeutics ... | JORDEN DAVID EMERSON | Director | Option Exercise | A | 0.94 | 10,000 | 9,400 | 10,000 | |
Mar 05 2012 | OPXA | Opexa Therapeutics ... | Richman Michael | Director | Option Exercise | A | 0.94 | 20,600 | 19,364 | 20,600 | |
Mar 05 2012 | OPXA | Opexa Therapeutics ... | Richman Michael | Director | Option Exercise | A | 0.94 | 10,000 | 9,400 | 10,000 | |
Mar 05 2012 | OPXA | Opexa Therapeutics ... | Maderis Gail J | Director | Option Exercise | A | 0.94 | 20,600 | 19,364 | 20,600 | |
Mar 05 2012 | OPXA | Opexa Therapeutics ... | Maderis Gail J | Director | Option Exercise | A | 0.94 | 10,000 | 9,400 | 10,000 | |
Mar 05 2012 | OPXA | Opexa Therapeutics ... | Seaman Scott B | Director | Option Exercise | A | 0.94 | 20,600 | 19,364 | 20,600 | |
Mar 05 2012 | OPXA | Opexa Therapeutics ... | Seaman Scott B | Director | Option Exercise | A | 0.94 | 10,000 | 9,400 | 10,000 | |
Jan 10 2012 | OPXA | Opexa Therapeutics ... | Rill Donna R | SVP of Operations | Option Exercise | A | 0.95 | 38,388 | 36,469 | 38,388 | |
Jan 10 2012 | OPXA | Opexa Therapeutics ... | Thompson Jaye | SVP of Clin Dev & R ... | Option Exercise | A | 0.95 | 38,388 | 36,469 | 38,388 | |
Jan 10 2012 | OPXA | Opexa Therapeutics ... | Warma Neil K | President & CEO | Option Exercise | A | 0.95 | 174,493 | 165,768 | 174,493 | |
Oct 28 2011 | OPXA | Opexa Therapeutics ... | Maderis Gail J | Director | Option Exercise | A | 1.05 | 1,756 | 1,844 | 1,756 | |
Oct 28 2011 | OPXA | Opexa Therapeutics ... | Maderis Gail J | Director | Option Exercise | A | 1.05 | 1,667 | 1,750 | 1,667 | |
Oct 28 2011 | OPXA | Opexa Therapeutics ... | Maderis Gail J | Director | Option Exercise | A | 1.05 | 20,000 | 21,000 | 20,000 | |
Apr 07 2011 | OPXA | Opexa Therapeutics ... | Hung David | Director | Option Exercise | A | 1.78 | 10,500 | 18,690 | 10,500 | |
Apr 07 2011 | OPXA | Opexa Therapeutics ... | Hung David | Director | Option Exercise | A | 1.78 | 10,000 | 17,800 | 10,000 | |
Apr 07 2011 | OPXA | Opexa Therapeutics ... | JORDEN DAVID EMERSON | Director | Option Exercise | A | 1.78 | 10,500 | 18,690 | 10,500 | |
Apr 07 2011 | OPXA | Opexa Therapeutics ... | JORDEN DAVID EMERSON | Director | Option Exercise | A | 1.78 | 10,000 | 17,800 | 10,000 | |
Apr 07 2011 | OPXA | Opexa Therapeutics ... | Richman Michael | Director | Option Exercise | A | 1.78 | 10,500 | 18,690 | 10,500 | |
Apr 07 2011 | OPXA | Opexa Therapeutics ... | Richman Michael | Director | Option Exercise | A | 1.78 | 10,000 | 17,800 | 10,000 | |
Apr 07 2011 | OPXA | Opexa Therapeutics ... | Seaman Scott B | Director | Option Exercise | A | 1.78 | 10,500 | 18,690 | 10,500 | |
Apr 07 2011 | OPXA | Opexa Therapeutics ... | Seaman Scott B | Director | Option Exercise | A | 1.78 | 10,000 | 17,800 | 10,000 | |
Jan 06 2011 | OPXA | Opexa Therapeutics ... | Warma Neil K | President & CEO | Option Exercise | A | 1.56 | 75,000 | 117,000 | 75,000 | |
Jan 06 2011 | OPXA | Opexa Therapeutics ... | Rill Donna R | SVP of Operations | Option Exercise | A | 1.56 | 25,000 | 39,000 | 25,000 | |
Jan 06 2011 | OPXA | Opexa Therapeutics ... | Thompson Jaye | SVP of Clin Dev & R ... | Option Exercise | A | 1.56 | 25,000 | 39,000 | 25,000 | |
Jun 15 2010 | OPXA | Opexa Therapeutics ... | Warma Neil K | President & CEO | Buy | P | 1.62 | 5,000 | 8,100 | 32,234 | 27.2 K to 32.2 K (+18.36 %) |
Jun 15 2010 | OPXA | Opexa Therapeutics ... | Warma Neil K | President & CEO | Buy | P | 1.64 | 3,000 | 4,920 | 27,234 | 24.2 K to 27.2 K (+12.38 %) |
Jun 15 2010 | OPXA | Opexa Therapeutics ... | JORDEN DAVID EMERSON | Director | Option Exercise | P | 2.00 | 13,000 | 26,000 | 145,000 | |
Jun 15 2010 | OPXA | Opexa Therapeutics ... | JORDEN DAVID EMERSON | Director | Buy | P | 1.62 | 28,091 | 45,507 | 890,000 | 861.9 K to 890 K (+3.26 %) |
Jun 10 2010 | OPXA | Opexa Therapeutics ... | Warma Neil K | President & CEO | Buy | C | 0.50 | 21,213 | 10,607 | 24,234 | 3 K to 24.2 K (+702.18 %) |
May 05 2010 | OPXA | Opexa Therapeutics ... | JORDEN DAVID EMERSON | Director | Option Exercise | A | 2.25 | 7,889 | 17,750 | 7,889 | |
May 05 2010 | OPXA | Opexa Therapeutics ... | JORDEN DAVID EMERSON | Director | Option Exercise | A | 2.25 | 10,000 | 22,500 | 10,000 | |
Jun 10 2010 | OPXA | Opexa Therapeutics ... | JORDEN DAVID EMERSON | Director | Buy | C | 0.50 | 52,805 | 26,403 | 861,909 | 809.1 K to 861.9 K (+6.53 %) |
Jun 10 2010 | OPXA | Opexa Therapeutics ... | JORDEN DAVID EMERSON | Director | Buy | C | 0.50 | 159,104 | 79,552 | 809,104 | 650 K to 809.1 K (+24.48 %) |
May 05 2010 | OPXA | Opexa Therapeutics ... | Hung David | Director | Option Exercise | A | 2.25 | 7,889 | 17,750 | 7,889 | |
May 05 2010 | OPXA | Opexa Therapeutics ... | Hung David | Director | Option Exercise | A | 2.25 | 10,000 | 22,500 | 10,000 | |
May 05 2010 | OPXA | Opexa Therapeutics ... | Seaman Scott B | Director | Option Exercise | A | 2.25 | 7,889 | 17,750 | 7,889 | |
May 05 2010 | OPXA | Opexa Therapeutics ... | Seaman Scott B | Director | Option Exercise | A | 2.25 | 10,000 | 22,500 | 10,000 | |
May 05 2010 | OPXA | Opexa Therapeutics ... | Richman Michael | Director | Option Exercise | A | 2.25 | 7,889 | 17,750 | 7,889 | |
May 05 2010 | OPXA | Opexa Therapeutics ... | Richman Michael | Director | Option Exercise | A | 2.25 | 10,000 | 22,500 | 10,000 | |
Dec 14 2009 | OPXA | Opexa Therapeutics ... | JORDEN DAVID EMERSON | Director | Buy | P | 1.95 | 25,000 | 48,700 | 650,000 | 625 K to 650 K (+4.00 %) |
Dec 02 2009 | OPXA | Opexa Therapeutics ... | Rill Donna R | Sr. V.P. of Operati ... | Option Exercise | A | 2.05 | 50,000 | 102,500 | 50,000 | |
Dec 02 2009 | OPXA | Opexa Therapeutics ... | Thompson Jaye | Sr VP Clin Dev & Re ... | Option Exercise | A | 2.05 | 50,000 | 102,500 | 50,000 | |
Dec 02 2009 | OPXA | Opexa Therapeutics ... | Warma Neil K | President & CEO | Option Exercise | A | 2.05 | 100,000 | 205,000 | 100,000 | |
Nov 16 2009 | OPXA | Opexa Therapeutics ... | JORDEN DAVID EMERSON | Director | Buy | P | 2.05 | 25,000 | 51,145 | 625,000 | 600 K to 625 K (+4.17 %) |
Oct 14 2009 | OPXA | Opexa Therapeutics ... | JORDEN DAVID EMERSON | Director | Option Exercise | X | 2.00 | 38,000 | 76,000 | 784,880 | |
Oct 14 2009 | OPXA | Opexa Therapeutics ... | JORDEN DAVID EMERSON | Director | Buy | X | 2.00 | 38,000 | 76,000 | 595,500 | 557.5 K to 595.5 K (+6.82 %) |
Nov 12 2009 | OPXA | Opexa Therapeutics ... | JORDEN DAVID EMERSON | Director | Option Exercise | P | 2.00 | 20,000 | 40,000 | 804,880 | |
Nov 12 2009 | OPXA | Opexa Therapeutics ... | JORDEN DAVID EMERSON | Director | Buy | P | 2.20 | 4,500 | 9,900 | 600,000 | 595.5 K to 600 K (+0.76 %) |
Sep 14 2009 | OPXA | Opexa Therapeutics ... | JORDEN DAVID EMERSON | Director | Option Exercise | P | 2.00 | 9,840 | 19,680 | 822,880 | |
Sep 10 2009 | OPXA | Opexa Therapeutics ... | Hung David | Director | Sell | S | 4.18 | 20,200 | 84,436 | 0 | 20.2 K to 0 (-100.00 %) |
Aug 27 2009 | OPXA | Opexa Therapeutics ... | Seaman Scott B | Director | Option Exercise | A | 1.47 | 8,000 | 11,760 | 149,089 | |
Aug 27 2009 | OPXA | Opexa Therapeutics ... | Richman Michael | Director | Option Exercise | A | 1.47 | 8,000 | 11,760 | 103,650 | |
Aug 27 2009 | OPXA | Opexa Therapeutics ... | McWilliams David | Director | Option Exercise | A | 1.47 | 8,000 | 11,760 | 246,668 | |
Aug 27 2009 | OPXA | Opexa Therapeutics ... | McWilliams David | Director | Option Exercise | J | 30.00 | 37,000 | 1,110,000 | 238,668 | |
Aug 27 2009 | OPXA | Opexa Therapeutics ... | JORDEN DAVID EMERSON | Director | Option Exercise | A | 1.47 | 8,000 | 11,760 | 813,040 | |
Aug 27 2009 | OPXA | Opexa Therapeutics ... | Hung David | Director | Option Exercise | A | 1.47 | 8,000 | 11,760 | 76,105 | |
Aug 27 2009 | OPXA | Opexa Therapeutics ... | Hung David | Director | Sell | S | 1.53 | 6,800 | 10,404 | 20,200 | 27 K to 20.2 K (-25.19 %) |
Aug 27 2009 | OPXA | Opexa Therapeutics ... | Hung David | Director | Sell | S | 1.43 | 20,000 | 28,600 | 27,000 | 47 K to 27 K (-42.55 %) |
Aug 21 2009 | OPXA | Opexa Therapeutics ... | Hung David | Director | Option Exercise | M | 1.17 | 10,000 | 11,700 | 68,105 | |
Aug 21 2009 | OPXA | Opexa Therapeutics ... | Hung David | Director | Sell | S | 1.60 | 5 | 8 | 47,000 | 47 K to 47 K (-0.01 %) |
Aug 21 2009 | OPXA | Opexa Therapeutics ... | Hung David | Director | Sell | M | 1.60 | 10,000 | 16,000 | 47,005 | 57 K to 47 K (-17.54 %) |
Aug 20 2009 | OPXA | Opexa Therapeutics ... | JORDEN DAVID EMERSON | Director | Option Exercise | A | 2.00 | 12,732 | 25,464 | 805,040 | |
Aug 20 2009 | OPXA | Opexa Therapeutics ... | JORDEN DAVID EMERSON | Director | Option Exercise | A | 2.00 | 24,928 | 49,856 | 792,308 | |
May 19 2009 | OPXA | Opexa Therapeutics ... | JORDEN DAVID EMERSON | Director | Option Exercise | A | 0.75 | 25,000 | 18,750 | 767,380 | |
May 19 2009 | OPXA | Opexa Therapeutics ... | JORDEN DAVID EMERSON | Director | Option Exercise | A | 0.50 | 50,000 | 25,000 | 742,380 | |
Apr 16 2009 | OPXA | Opexa Therapeutics ... | Warma Neil K | Pres & CEO | Option Exercise | A | 0.75 | 10,000 | 7,500 | 433,021 | |
Apr 16 2009 | OPXA | Opexa Therapeutics ... | Warma Neil K | Pres & CEO | Option Exercise | A | 0.50 | 20,000 | 10,000 | 423,021 | |
Apr 16 2009 | OPXA | Opexa Therapeutics ... | JORDEN DAVID EMERSON | Director | Option Exercise | A | 0.75 | 75,000 | 56,250 | 692,380 | |
Apr 16 2009 | OPXA | Opexa Therapeutics ... | JORDEN DAVID EMERSON | Director | Option Exercise | A | 0.50 | 150,000 | 75,000 | 617,380 | |
Feb 09 2009 | OPXA | Opexa Therapeutics ... | Rill Donna R | Sr. V.P. of Operati ... | Option Exercise | A | 0.47 | 8,396 | 3,946 | 151,776 | |
Feb 09 2009 | OPXA | Opexa Therapeutics ... | Williams Jimmy Calvin | Chief Operating Off ... | Option Exercise | A | 0.47 | 28,643 | 13,462 | 162,573 | |
Feb 09 2009 | OPXA | Opexa Therapeutics ... | McWilliams David | Director | Option Exercise | A | 0.47 | 8,000 | 3,760 | 275,668 | |
Feb 09 2009 | OPXA | Opexa Therapeutics ... | Hung David | Director | Option Exercise | A | 0.47 | 8,000 | 3,760 | 78,105 | |
Feb 09 2009 | OPXA | Opexa Therapeutics ... | Richman Michael | Director | Option Exercise | A | 0.47 | 29,250 | 13,748 | 95,650 | |
Feb 09 2009 | OPXA | Opexa Therapeutics ... | Seaman Scott B | Director | Option Exercise | A | 0.47 | 8,000 | 3,760 | 141,089 | |
Feb 09 2009 | OPXA | Opexa Therapeutics ... | Seaman Scott B | Director | Option Exercise | A | 0.47 | 28,250 | 13,278 | 133,089 | |
Feb 09 2009 | OPXA | Opexa Therapeutics ... | JORDEN DAVID EMERSON | Director | Option Exercise | A | 0.47 | 8,000 | 3,760 | 467,380 | |
Feb 09 2009 | OPXA | Opexa Therapeutics ... | JORDEN DAVID EMERSON | Director | Option Exercise | A | 0.47 | 6,880 | 3,234 | 459,380 | |
Jan 20 2009 | OPXA | Opexa Therapeutics ... | Rill Donna R | Senior V.P. of Oper ... | Option Exercise | A | 0.22 | 40,000 | 8,800 | 143,380 | |
Jan 20 2009 | OPXA | Opexa Therapeutics ... | Warma Neil K | President & CEO | Option Exercise | A | 0.22 | 150,000 | 33,000 | 403,021 | |
Jan 20 2009 | OPXA | Opexa Therapeutics ... | Hohlfeld Lynne | CFO | Option Exercise | A | 0.22 | 20,000 | 4,400 | 116,000 | |
Sep 23 2008 | OPXA | Opexa Therapeutics ... | ROTH MICHAEL | 10% Owner | Sell | S | 0.25 | 500 | 125 | 359,674 | 360.2 K to 359.7 K (-0.14 %) |
Sep 23 2008 | OPXA | Opexa Therapeutics ... | ROTH MICHAEL | 10% Owner | Sell | S | 0.26 | 250,000 | 63,975 | 360,174 | 610.2 K to 360.2 K (-40.97 %) |
Sep 23 2008 | OPXA | Opexa Therapeutics ... | ROTH MICHAEL | 10% Owner | Sell | S | 0.21 | 195,000 | 40,248 | 610,174 | 805.2 K to 610.2 K (-24.22 %) |
Sep 23 2008 | OPXA | Opexa Therapeutics ... | ROTH MICHAEL | 10% Owner | Sell | S | 0.21 | 184,376 | 39,254 | 805,174 | 989.6 K to 805.2 K (-18.63 %) |
Sep 04 2008 | OPXA | Opexa Therapeutics ... | MARXE AUSTIN W & GREENHOUSE DA ... | 10% Owner | Sell | S | 2.39 | 25,000 | 59,765 | 746,848 | 771.8 K to 746.8 K (-3.24 %) |
Sep 04 2008 | OPXA | Opexa Therapeutics ... | MARXE AUSTIN W & GREENHOUSE DA ... | 10% Owner | Sell | S | 2.45 | 1,000 | 2,450 | 771,848 | 772.8 K to 771.8 K (-0.13 %) |
Aug 21 2008 | OPXA | Opexa Therapeutics ... | JORDEN DAVID EMERSON | Director | Option Exercise | A | 1.55 | 20,000 | 31,000 | 452,500 | |
Aug 13 2008 | OPXA | Opexa Therapeutics ... | Warma Neil K | President & CEO | Option Exercise | A | 1.78 | 3,021 | 5,377 | 253,021 | |
Aug 13 2008 | OPXA | Opexa Therapeutics ... | Warma Neil K | President & CEO | Grant | A | 1.66 | 3,021 | 5,000 | 3,021 | 0 to 3 K |
Aug 13 2008 | OPXA | Opexa Therapeutics ... | Seaman Scott B | Director | Option Exercise | A | 1.78 | 15,105 | 26,887 | 104,839 | |
Aug 13 2008 | OPXA | Opexa Therapeutics ... | Seaman Scott B | Director | Grant | A | 1.66 | 15,105 | 24,999 | 43,655 | 28.6 K to 43.7 K (+52.91 %) |
Aug 13 2008 | OPXA | Opexa Therapeutics ... | Hung David | Director | Option Exercise | A | 1.78 | 15,105 | 26,887 | 70,105 | |
Aug 13 2008 | OPXA | Opexa Therapeutics ... | Hung David | Director | Grant | A | 1.66 | 15,105 | 24,999 | 47,005 | 31.9 K to 47 K (+47.35 %) |
Jun 30 2008 | OPXA | Opexa Therapeutics ... | Rill Donna R | V.P. Operations | Option Exercise | A | 1.17 | 33,000 | 38,610 | 103,380 | |
Jun 30 2008 | OPXA | Opexa Therapeutics ... | Williams Jimmy Calvin | Chief Operating Off ... | Option Exercise | A | 1.17 | 23,000 | 26,910 | 133,930 | |
Jun 30 2008 | OPXA | Opexa Therapeutics ... | Hohlfeld Lynne | CFO | Option Exercise | A | 1.17 | 21,000 | 24,570 | 96,000 | |
Jun 30 2008 | OPXA | Opexa Therapeutics ... | Seaman Scott B | Director | Option Exercise | A | 1.17 | 10,000 | 11,700 | 89,734 | |
Jun 30 2008 | OPXA | Opexa Therapeutics ... | McWilliams David | Director | Option Exercise | A | 1.17 | 39,000 | 45,630 | 267,668 | |
Jun 30 2008 | OPXA | Opexa Therapeutics ... | McWilliams David | Director | Option Exercise | A | 1.17 | 10,000 | 11,700 | 228,668 | |
Jun 30 2008 | OPXA | Opexa Therapeutics ... | Richman Michael | Director | Option Exercise | A | 1.17 | 10,000 | 11,700 | 66,400 |